至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy.

Annals of the New York Academy of Sciences. 2018-08; 
Weidong Zhang,Adebayo J. Molehin,Juan U. Rojo,Justin Sudduth,Pramodh K. Ganapathy,Eunjee Kim,Arif J. Siddiqui,Jasmin Freeborn,Souad R. Sennoune,Jordan May,Samra Lazarus,Catherine Nguyen,Whitni K. Redman,Gul Ahmad,Workineh Torben,Souvik Karmakar,Loc Le,Kameswara R. Kottapalli,Pratibha Kottapalli,Roman F. Wolf,James F. Papin,David Carey,Sean A. Gray,Jenn D. Bergthold,Raymond T. Damian,Bryan T. Mayer,Florian Marks,Steven G. Reed,Darrick Carter,and Afzal A. Siddiqu
Products/Services Used Details Operation
PCR Cloning and Subcloning The coding sequenceof Sm-p80 was cloned into a pCold II vec-tor (GenScript, Piscataway, NJ), and protein wasexpressed inEscherichia colistrain BL21 (DE3). Get A Quote

摘要

关键词

Sm-p80 vaccine; schistosomiasis;Schistosoma mansoni; baboons; systems biology; efficacy